Literature DB >> 23445630

Elevated coronary whole blood viscosity in acute coronary syndrome patients.

Sang-Rok Lee1, Jin-Mu Jung, Lae-Young Jung, Ju-Hyung Lee, Sun-Hwa Lee, Kyoung-Suk Rhee, Jei Keon Chae, Won Ho Kim, Jae Ki Ko, Dong-Hwan Lee, Robert S Rosenson.   

Abstract

OBJECTIVES: As most clinical studies measure whole blood viscosity (WBV) from peripheral samples, potential differences in WBV obtained from the coronary arteries are often ignored. This study investigated differences in WBV measured from coronary artery specimens in patients with and without acute coronary syndrome (ACS). METHODS AND
RESULTS: Consecutive patients with chest pain who underwent diagnostic coronary angiography were divided into two groups [non-ACS (n = 16), ACS (n = 22)]. The ACS group consisted of unstable angina (n = 13) and acute myocardial infarction (n = 9) patients. Two blood samples were obtained from each patient at the both coronary artery ostia prior to coronary angiography. Low-shear and high-shear blood viscosities (BVs) were measured at shear rates of 1 and 300 s-1, respectively, by a scanning capillary tube viscometer (Bio-Visco Inc., South Korea). Both low-shear and high-shear BVs obtained from peripheral, left and right coronary arteries were not different in both groups. Mean coronary low-shear WBV values obtained in ACS group were 29.2% higher than those in non-ACS group (295.3 ± 87.2 mP vs. 228.5 ± 69.2 mP, p = 0.016). Mean coronary high-shear WBV values obtained in ACS group were 15.6% higher than those in non-ACS group (42.9 ± 10.0 mP vs. 37.1 ± 4.6 mP, p = 0.036).
CONCLUSIONS: Direct measurement of WBV from the coronary artery showed no differences with peripheral samples. Future larger studies are needed to clarify our results.

Entities:  

Keywords:  Acute coronary syndrome; blood viscosity; coronary vessels; wall shear stress

Mesh:

Year:  2013        PMID: 23445630     DOI: 10.3233/CH-131692

Source DB:  PubMed          Journal:  Clin Hemorheol Microcirc        ISSN: 1386-0291            Impact factor:   2.375


  4 in total

1.  Improvement and Application of Acute Blood Stasis Rat Model Aligned with the 3Rs (Reduction, Refinement and Replacement) of Humane Animal Experimentation.

Authors:  Shuai Huang; Feng Xu; Yin-Ye Wang; Ming-Ying Shang; Chao-Qun Wang; Xuan Wang; Shao-Qing Cai
Journal:  Chin J Integr Med       Date:  2014-12-23       Impact factor: 1.978

2.  Rosuvastatin Reduces Blood Viscosity in Patients with Acute Coronary Syndrome.

Authors:  Lae-Young Jung; Sang-Rok Lee; Jin-Mu Jung; Yi-Shik Kim; Sun-Hwa Lee; Kyoung-Suk Rhee; Jei-Keon Chae; Dong-Hwan Lee; Dal-Sik Kim; Won-Ho Kim; Jae-Ki Ko
Journal:  Korean Circ J       Date:  2016-03-21       Impact factor: 3.243

3.  Determination of hemodynamic risk for vascular disease in planar artery bifurcations.

Authors:  Alberto Otero-Cacho; María Aymerich; M Teresa Flores-Arias; Miguel Abal; Ezequiel Álvarez; Vicente Pérez-Muñuzuri; Alberto P Muñuzuri
Journal:  Sci Rep       Date:  2018-02-12       Impact factor: 4.379

4.  Therapeutic Efficacy and Safety of Safflower Injection in the Treatment of Acute Coronary Syndrome.

Authors:  Qiang Lu; Jiamin Xu; Qian Li; Wenzhen Wu; Yuling Wu; Jianhui Xie; Xiaobo Yang
Journal:  Evid Based Complement Alternat Med       Date:  2021-03-16       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.